Tuesday, 07 Apr 2020

You are here

Tofacitinib as Monotherapy Following MTX Withdrawal in PsA: Dr. Eric Ruderman

Dr. Ruderman describes abstract #L14 presented at the 2019 ACR/ARP annual meeting in Atlanta.

Add new comment

Want to talk about this video? Comment here to lead the discussion.
MORE VIDEOS

Dr. Jack Cush interviews Lilly...

23 Oct 2018

The Week in Review: 5 February 2016

08 Feb 2016

Dr. Kevin Winthrop - Expert Advice on...

21 Jun 2019

Welcome to ACR 2019: Dr. Jack Cush

10 Nov 2019

The RheumNow Week in Review – 28 April...

30 Apr 2017

Dr. Arthur Lau: FRAME Study

14 Nov 2016

Dr. Bill Shergy: Handling DMARDs and...

19 Dec 2016

RheumNow Podcast – More Than a Spot of...

02 Aug 2019

The RheumNow Week in Review – 17...

17 Feb 2017

The RheumNow Week in Review – 7 April...

07 Apr 2017

Dr. Arthur Lau: SELECT-COMPARE Trial

23 Oct 2018

The RheumNow Week in Review – 28 July...

28 Jul 2017